This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: DC cardioversion

Dabigatran improves the efficiency of an elective direct current cardioversion service 

February 2014 Br J Cardiol 2014;21:29–32 doi:10.5837/bjc.2014.002 Online First

Dabigatran improves the efficiency of an elective direct current cardioversion service 

Wai Kah Choo, Shona Fraser, Gareth Padfield, Gordon F Rushworth, Charlie Bloe, Peter Forsyth, Stephen J Cross, Stephen J Leslie

Abstract

Introduction Atrial fibrillation (AF) is a common arrhythmia affecting approximately 1% of the general population, this rises to 18% in those aged 85 years and above.1 The most effective method for correcting persistent AF is direct current cardioversion (DCCV). However, DCCV is associated with an increased risk of thromboembolic events.2 Anticoagulation with warfarin reduces the risk of thromboembolism from approximately 6% to less than 1%.3 The current recommendations advise therapeutic anticoagulation for at least three weeks prior to, and four weeks after cardioversion.4 A nurse-led elective DCCV service at Raigmore Hospital was establish

| Full text

For healthcare professionals only

Add Banner

Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now